AxoGen Inc (AXGN)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AxoGen Inc (AXGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011902
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions for peripheral nerve injuries. The company offers AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products. It also offers clinical research studies in understanding and outcome of peripheral nerve regeneration and reconstruction projects. AxoGen’s clinical research programs comprise the CHANGE study, the RANGER study, and the RECON study programs. The company sells its products through a network of distributors in the US and abroad. AxoGen is headquartered in Alachua, Florida, the US.

AxoGen Inc (AXGN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AxoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AxoGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AxoGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AxoGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AxoGen Inc, Medical Devices Deals, 2011 to YTD 2017 9
AxoGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AxoGen Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 11
AxoGen Raises USD17.5 Million in Private Placement of Shares 12
AxoGen Raises USD15 Million in Public Offering of Shares 14
AxoGen Inc – Key Competitors 15
AxoGen Inc – Key Employees 16
AxoGen Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 01, 2017: AxoGen Reports 2017 Third Quarter Financial Results 18
Aug 02, 2017: AxoGen Reports 2017 Second Quarter Financial Results 19
May 04, 2017: AxoGen Reports 2017 First Quarter Financial Results 20
Feb 22, 2017: AxoGen Reports 2016 Fourth Quarter and Full Year Financial Results 21
Jan 09, 2017: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue 23
Nov 02, 2016: AxoGen Reports Financial Results for Third Quarter 2016 24
Aug 03, 2016: AxoGen Reports Financial Results for Second Quarter 2016 25
May 04, 2016: AxoGen First Quarter Revenue Increases 64% Over Prior Year to $8.1 Million 26
Corporate Communications 27
Jul 17, 2017: AxoGen Appoints Jon Gingrich Chief Commercial Officer 27
Sep 19, 2016: AxoGen Appoints Amy Wendell to Board of Directors 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
AxoGen Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
AxoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AxoGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AxoGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AxoGen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
AxoGen Inc, Medical Devices Deals, 2011 to YTD 2017 9
AxoGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 11
AxoGen Raises USD17.5 Million in Private Placement of Shares 12
AxoGen Raises USD15 Million in Public Offering of Shares 14
AxoGen Inc, Key Competitors 15
AxoGen Inc, Key Employees 16
AxoGen Inc, Other Locations 17
AxoGen Inc, Subsidiaries 17

★海外企業調査レポート[AxoGen Inc (AXGN)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vitasoy International Holdings Limited (345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Limited (345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Charkit Chemical Company LLC:企業の戦略・SWOT・財務情報
    Charkit Chemical Company LLC - Strategy, SWOT and Corporate Finance Report Summary Charkit Chemical Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Extreme Networks, Inc. (EXTR):企業の財務・戦略的SWOT分析
    Extreme Networks, Inc. (EXTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Fastenal Co:企業の戦略・SWOT・財務情報
    Fastenal Co - Strategy, SWOT and Corporate Finance Report Summary Fastenal Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Lotus Pharmaceutical Co Ltd (1795):企業の財務・戦略的SWOT分析
    Summary Lotus Pharmaceutical Co Ltd (Lotus Pharmaceutical), a subsidiary of Alvogen Inc is a pharmaceutical company that develops and sells pharmaceutical products. The company provides products that are used in the treatment of rheumatology, cancer, cardiology, dyslipidemia, hypertension, woman hea …
  • Net One Systems Co Ltd (7518):企業の財務・戦略的SWOT分析
    Net One Systems Co Ltd (7518) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Yellowstone Valley Electric Cooperative, Inc.:発電所・企業SWOT分析
    Yellowstone Valley Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • Exonate Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Exonate Ltd (Exonate) is a biopharmaceutical company that discovers and develops small molecule drugs, which modulates the alternative mRNA splicing for the treatment of unmet medical needs. The company’s alternative mRNA splicing is modulated in disease states that results in the pathologic …
  • TIM SpA (TIT):企業の財務・戦略的SWOT分析
    TIM SpA (TIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • RELX Group plc:企業の戦略・SWOT・財務情報
    RELX Group plc - Strategy, SWOT and Corporate Finance Report Summary RELX Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Australian Postal Corporation:戦略・SWOT・企業財務分析
    Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report Summary Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Australian Broadcasting Corporation:企業の戦略的SWOT分析
    Australian Broadcasting Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Tocardo International BV:電力:M&Aディール及び事業提携情報
    Summary Tocardo International BV (Torcado), a subsidiary of Tribute Resources Inc, is an energy equipment provider that manufactures and markets offshore turbines. The company offers wind turbines, sea defences, commercial demonstrator and others. It also offers river and tidal turbines. Torcado’s p …
  • Peace River Electric Cooperative, Inc.:企業の発電所・SWOT分析2018
    Peace River Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • DeepOcean Group Holding BV:企業の戦略的SWOT分析
    DeepOcean Group Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Split Rock Partners, LLC:企業の戦略・SWOT・財務情報
    Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report Summary Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AA PLC:企業の戦略・SWOT・財務情報
    AA PLC - Strategy, SWOT and Corporate Finance Report Summary AA PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • GE Healthcare:企業のM&A・事業提携・投資動向
    GE Healthcare - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GE Healthcare Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • GW Pharmaceuticals Plc (GWP):製薬・医療:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Dairygold Co-operative Society Ltd:企業の戦略的SWOT分析
    Dairygold Co-operative Society Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆